Identification of novel biomarkers for the early detection of cancer
ProteoMediX has raised €10M across 4 funding rounds from 1 investor, most recently a Series C round in Aug 2016. Based in Schlieren, Switzerland; founded 2010; active in Healthtech. Acquired by Blue Water Biotech in 2023. Data as of 6 Aug 2026.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2016-08-01 | Series C | €4.6M | Altos Ventures | View deal → |
| 2015-01-01 | Series B | €900k | — | View deal → |
| 2014-04-01 | Series B | €2.6M | — | View deal → |
| 2012-01-01 | Series A | €2.1M | — | View deal → |
